AwardedSpainGoods€14,977,367
4 Prorroga-Suministro de VUTRISIRAN (AMVUTTRA 25 mg solución inyectable jeringa) de distribución exclusiva, con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
- Published
- Published 3 February 2025
Overview
Hospital Clínico San Carlos de Madrid has awarded a contract for the supply of Vutrisiran (AMVUTTRA 25 mg injectable solution in pre-filled syringes) with exclusive distribution rights to its Pharmacy Service. The contract, valued at 2,880,262.80 EUR, was awarded to Alnylam Pharmaceuticals Spain, S.L. on 19 July 2026 as a fourth extension to an existing supply agreement.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €14,977,367
- Procedure
- Direct
- Published
- 3 February 2025
Pharmaceutical products
Award outcome
- Awarded value
- €2,880,263
- Award date
- 19 July 2026
- Contract period
- — → 15 January 2027
- ALNYLAM PHARMACEUTICALS SPAIN, S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 July 2026
Contract Award Notice
4 February 2026
Contract Award Notice
23 July 2025
Contract Award Notice
3 February 2025
Contracting authority
HOSPITAL CLINICO SAN CARLOS DE MADRID
Procuring entityMADRID, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.